Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_assertion type Assertion NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_head.
- NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_provenance.
- NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_assertion evidence source_evidence_literature NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_provenance.
- NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_assertion SIO_000772 21833654 NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_provenance.
- NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_assertion wasDerivedFrom befree-20150227 NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_provenance.
- NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_assertion wasGeneratedBy ECO_0000203 NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_provenance.